Determination of interferon-α2 allele composition in the genomic DNA from healthy volunteers and leukemic patients in Japan

Journal of Interferon and Cytokine Research

Volumn 17, Issue 3, 1997, Pages 135-140

  Kita, Masakazu ^a   Tanaka, Koji ^a   Uoshima, Nobuhiko ^a   Kobayashi, Yutaka ^a   Ozawa, Masaru ^a   Kondo, Motoharu ^a   Imanishi, Jiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; NUCLEOTIDE; ALPHA2A INTERFERON; ALPHA2B INTERFERON; DNA; RECOMBINANT INTERFERON;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENOME; HUMAN; HUMAN CELL; JAPAN; LEUKEMIA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN VARIANT; CASE CONTROL STUDY; CELL LINE; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REFERENCE VALUE; RESTRICTION MAPPING;

ADULT; AGED; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; CELL LINE; DNA; DNA, NEOPLASM; FEMALE; GENOME, HUMAN; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON TYPE I, RECOMBINANT; JAPAN; LEUKEMIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; REFERENCE VALUES; RESTRICTION MAPPING;

EID: 0030610408     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.135     Document Type: Article

References (32)

1. GOEDDEL, D.V., YELVERTON, E., ULLRICH, A., HEYNEKER, H.L., MIOZZARI, G., HOLMES, N., SEEBURG, P.H., DULL, T., MAY, L., STEBBING, N., CREA, R., MAEDA, S., McCANDLISS, R., SLOMA, A., TABOR, J.M., GROSS, M., FAMILLETTI, P.C., and PESTKA, S. (1980). Human leukocyte interferon production by E. coli is biologically active. Nature 287, 411-416.
2. STREULI, M., NAGATA, S., and WEISSMANN, C. (1980). At least three human type α interferons: structure of α2. Science 209, 1343-1347.
3. BODO, G., and FOGY, I. (1985). Characterization of different molecular species in affinity purified recombinant human interferon α2. In: The Interferon System. F. Dianzani and G.-B. Rossi (eds.) Serono Symposia Publications, Vol. 24. New York: Raven Press, pp. 23-27.
4. DOOLEY, J.S., DAVIS, G.L., PETERS, M., WAGGONER, J.G., GOODMAN, Z., and HOOFNAGLE, J.H. (1986). Pilot study of recombinant human α-interferon for chronic type B hepatitis. Gastroenterology 90, 150-157.
5. MILELLA, M., ANTONELLI, G., SANTANTONIO, T., CURRENTI, M., MONNO, L., MARIANO, N., ANGARANO, G., DIANZANI, F., and PASTORE, G. (1993). Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection. Liver 13, 146-150.
6. ANTONELLI, G., CURRENTI, M., TURRIZIANI, O., and DIANZANI, F. (1991). Neutralizing antibodies to interferon alpha: relative frequency in patients treated with different IFN preparations. J. Infect. Dis. 163, 882-885.
7. QUESDA, J.R., HAWKINS, M., HORNINGS, S., ALEXANIAN, R., BORDEN, E., MERIGAN, T., ADAMS, F., and GUTTERMAN, J.U. (1984). Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma. Am. J. Med. 77, 427-432.
8. JONES, G.J., and ITRI, L.M. (1986). Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients. Cancer 9, S1709-1715.
9. SPIEGEL, R.J., SPICHEHANDLER, J.R., JACOBS, S.L., and ODEN, E.M. (1986). Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A). Am. J. Med. 80, 223-228.
10. DIANZANI, F., ANTONELLI, G., AMICUCCI, P., CEFARO, A., and PINTUS, C. (1989). Low incidence of neutralizing antibody formation to interferon-a2b in human recipients. J. Interferon Res. 9, S33-6.
11. STEIS, R.G., SMITH, J.W., URBA, W.J., CLARK, J.W., ITRI, L.M., EVANS, L.M., SCHOENBERGER, C., and LONGO, D.L. (1988). Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies. N. Engl. J. Med. 318, 1409-1413.
12. IKEDA, Y., MIYAKE, K., TODA, G., YAMADA, H., YAMANAKA, M., and OKA, H. (1989). Detection of anti-interferon-a2a antibodies in chronic liver disease. J. Gastroenterol. Hepatol. 4, 411-418.
13. LEE, N., NI, D., BRISSETTE, R., CHOU, M., HUSSAIN, M., GILL, D.S., LIAO, M., and TESTA, D. (1995). Interferon-a2 variants in the human genome. J. Interferon Res. 15, 341-349.
14. HIGUCHI, R. (1981). Using PCR to engineer DNA. In: PCR Technology: Principles and Applications for DNA Amplification. H.A. Erlich (ed.) New York: Stockton Press.
15. GEWERT D., SALOM, C., BARBER, K., MACBRIDE, S., COOPER, H., LEWIS, A., WOOD, J., and CROWE, S. (1993). Analysis of interferon-α2 sequences in human genomic DNA. J. Interferon Res. 13, 227-231.
16. HENKO, K., BROSIUS, F.J., FUJISAWA, A., FUJISAWA, J.-I., HAYNES, J.R., HOCHSTADT, J., KOVACIC, T., PASEK, M., SCHAMBECK, A., SCHMID, J., TODOKORA, K., WALCHLI, M., NAGATA, S., and WEISSMANN, C. (1985). Structural relationship of human interferon alpha genes and pseudogenes. J. Mol. Biol. 185, 227-260.
17. WEISSMANN, C., and WEBER, H. (1986). The interferon genes. Prog. Nucleic Acid Res. Mol. Biol. 33, 251-260.
18. ZOON, K.C., MILLER, D., BEKISZ, J., ZUR NEDDEN, D., ENTERLINE, J.C., NGUYEN, N.Y., and HU, R-Q. (1992). Purification and characterization of multiple components of human lymphoblastoid interferon-α. J. Biol. Chem. 267, 15210-15216.
19. DIAZ, M.O., ZIEMIN, S., LE BEAU, M.M., PITHA, P., SMITH, S.D., CHILCOTE, R.R., and ROWLEY, J.D. (1988). Homozygous deletion of the α- and β1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA 85, 5259-5263.
20. LAWN, R.M., CROSS, M., HOUCK, C.M., FRANCKE, A.E., GRAY, P.V., and GOEDDEL, D.V. (1981). DNA sequence of a major human leukocyte interferon gene. Proc. Natl. Acad. Sci. USA 78, 5435-5439.
21. EINHORN, S., GRANDER, D., BJORK, O., BRONDUM-NIELSEN, K., and SODERHALL, S. (1990). Deletion of α-, β-and ω-interferon genes in malignant cells from children with acute lymphocytic leukemia. Cancer Res. 50, 7781-7785.
22. MIDDLETON, P.G., PRINCE, R.A., WILLIAMSON, I.K., TAYLOR, P.R.A., REID, M.M., JACKSON, G.H., KATZ, F., CHESSELLS, J.M., and PROCTOR, S.J. (1991). Alpha interferon gene deletion in adults, children and infants with acute lymphoblastic leukemia. Leukemia 5, 680-682.
23. COLAMONICI, O.R., DOMANSKI, P., PLATANIAS, L.C., and DIAZ, O. (1992). Correlation between interferon (IFN) a resistance and deletion of the IFN α/β genes in acute leukemia cell lines suggests selection against the IFN system. Blood 80, 744-749.
24. HOSOI, H., IMAI, M., and YAMANAKA, M. (1992). The interferon-α2b gene in Japanese patients with chronic viral hepatitis who developed antibodies after treatment with recombinant interferon-α2a. J. Gastroenterol. Hepatol. 7, 411-416.
25. LIAO, M.J., LEE, N., DIPAOLA, M., HUSSAIN, M., BRISSETTE, R., NI, D., SMITH, T., DESAI, M., FERENCZ-BIRO, K., and TESTA, D. (1994). Distribution of interferon-α2 genes in humans. J. Interferon Res. 14, 183-185.
26. EMANUEL, S.L., and PESTKA, S. (1993). Human interferon-αA, -α2 and α2(Arg) genes in genomic DNA. J. Biol. Chem. 268, 12565-12569.
27. CROWE, J.S., GEWERT, D.R., BARBER, K.A., LEWIS, A.P., SIMS, M.J., DAVIES, S.L., SALOM, C.L. WOOD, J., THOMAS, H.C., THURSZ, M., and LOK, A.S. (1994). Iterferon(IFN)-α2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-α2a therapy. J. Infect. Dis. 169, 875-878.
28. DIPAOLA, M., SMITH, T., FERENCZ-BIRO, K., LIAO, M.J., and TESTA, D. (1994). Interferon-α2 produced by normal human leukocytes is predominantly interferon-α2b. J. Interferon Res. 14, 325-332.
29. WUSSOW, P.V., HEHLMANN, R., HOCHHAUS, T.J., AKSCHIES, D., NOLTE, K.U., PRUMMER, O., ANSARI, H., HASFORD, J., HEIMPEL, H., and DEICHER, H. (1994). Roferon (rIFN-α2a) is more immunogenic than Intron A (rIFN-α2b) in patients with chronic myelogenous leukemia. J. Interferon Res. 14, 217-219.
30. ANTONELLI, G., GIANNELLI, G., PISTELLO, M., MAGGI, F., VATTERONI, L., CURRENTI, M., VECCHIO, S.D., ROFFI, L., PASTORE, G., and DIANZANI, F. (1994). Clinical significance of recombinant interferon-α2 neutralizing antibodies in hepatitis patients. J. Interferon Res. 14, 211-213.
31. OBERG, K.E. (1994). Autoimmunity and antibodies to interferons in patients with carcinoid tumors - clinical consequences. J. Interferon Res. 14, 215-216.
32. GEWERT, D.R., SHARP, N.A., BARBER, K.A., COOPER, H., TUCKER, D., LEWIS, A.P., THURSZ, M., and CROWE, S. (1995). Detection of rare allelic variants of the interferon-α2 gene in human genomic DNA. J. Interferon Res. 15, 403-406.